CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Applied Therapeutics, Inc.

APLT
$15M
Micro Cap
NASDAQPharmaceutical Preparations🇺🇸North AmericaNEW YORK28 employees

Drugs in Pipeline

2

Phase 3 Programs

2

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

APLT News
Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Drug Pipeline

AT-001

Phase 3

Diabetic Cardiomyopathies

AT-007

Phase 3

Hereditary Neuropathy Caused by SORD Deficiency

Diabetic Cardiomyopathies

1 drug in this indication

Classic Galactosemia

1 drug in this indication

Hereditary Neuropathy Caused by SORD Deficiency

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

📑
Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
→
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply